Pharmacy Daily for Wed 17 Oct 2012 - Sigma class action, Naproxen approval, Sukin training, Health

Embed Size (px)

Citation preview

  • 7/31/2019 Pharmacy Daily for Wed 17 Oct 2012 - Sigma class action, Naproxen approval, Sukin training, Health

    1/4

    Future Proofing the Consumer Healthcare Industry will feature an impressive collection ofAustralian and international key opinion leaders and experts from industry, pharmacy, academia,general practice and government including:

    Dr John Skerritt, National Manager of the Therapeutic Goods Administration (TGA) Dr Stewart Jessamine, Group Manager Corporate, Medsafe NZ John Bronger, President of the Pharmaceutical Society of Australia NSW Branch Dr Geoffrey Annison, Deputy Chief Executive of the Australian Food & Grocery Council (AFGC) George Negus, legendary TV presenter and journalist David E Webber, Director-General of the World Self Medication Industry (WSMI) David Skinner, President of ASMIs sister association, Consumer Health Products Canada

    A must for anyone interested in consumer healthcare including marketing, regulatoryand sales personnel, government and consumer representatives, advertising/PRagencies, healthcare recruiters, academics and healthcare professionals.

    A combination of keynote presentations and panel debates will cover topics such asdeveloping a world class regulatory system in Australia; the changing face of consumerbehaviour and the healthcare retailing landscape; the increasing use of technology inthe healthcare space, and the latest trends within and outside the consumer healthcareindustry that could impact the industrys future.

    REGISTER NOW!www.asmi.com.au/events

    Dr John Skerritt John Bronger George Negus

    FUTURE PROOFING THE CONSUMER HEALTHCARE INDUSTRYWaterview Convention Centre, Sydney Olympic Park. Tuesday 13 November 2012

    http://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/eventshttp://www.traveldaily.com.au/click/redirect.asp?url=http://www.asmi.com.au/events
  • 7/31/2019 Pharmacy Daily for Wed 17 Oct 2012 - Sigma class action, Naproxen approval, Sukin training, Health

    2/4

    3 + $ 5 0 $& < ' $ , /

  • 7/31/2019 Pharmacy Daily for Wed 17 Oct 2012 - Sigma class action, Naproxen approval, Sukin training, Health

    3/4

    3 + $ 5 0 $& < ' $ , /

  • 7/31/2019 Pharmacy Daily for Wed 17 Oct 2012 - Sigma class action, Naproxen approval, Sukin training, Health

    4/4

    IMPORTANT NOTICE REQUIRING ACTION BEFORE C.O.B. 19 OCTOBER

    CLASS ACTION AGAINST SIGMA PHARMACEUTICALS LIMITED

    Did you purchase shares in Sigma Pharmaceuticals Ltd (Sigma) between7 September 2009 and 25 February 2010?

    For further information Call1800 555 777

    A securities class action against Sigma was commenced in the Federal Court of Australia in October 2010 (VID933/2010).

    The Federal Court has ordered the matter for mediation, which is scheduled for next week.

    The class action is being run by Slater & Gordon with litigation funding provided by Comprehensive Legal Funding LLC(Comprehensive). Significant progress has been made in the litigation, including the provision and review of thedefendants discovered documents.

    The proceeding was commenced only on behalf of those investors that acquired an interest in Sigma shares during theClaim Period and who executed a litigation funding agreement with Comprehensive prior to the commencement ofproceedings. The group of persons to benefit from the class action was at one stage expanded to include persons whosigned a litigation funding agreement after the litigation commenced but before a particular date. That date has sincepassed (a Funded Group Member).

    Accordingly, if you are not a Funded Group Member you will not be entitled to participate in any damages distribution inthis proceeding (including in the event that the case settles at mediation).

    Purpose of this NoticeThe purpose of this notice is to inform investors that they might have legal rights, and that those rights might be affectedby the class action. Investors will only be eligible to participate in the claim if they acquired an interest in Sigma sharesduring the claim period.

    Investors are not obliged to take any action in response to this notice. If you purchased shares during the claim periodbut elect not participate in the class action, you will not receive compensation in the proceeding. However, any legalrights you might individually possess against Sigma will not be compromised by you not responding to this bulletin. Inother words, if you are not already a group member in the proceeding, and you choose not to take steps to join therepresented group, you will retain your rights to bring your own legal proceedings against Sigma if you wish to.

    Opportunity to ParticipateIf you are not currently a Funded Group Member but acquired an interest in Sigma shares during the claim period andwould like to participate in the proceeding, please follow the instructions under the section labeled Contact. Pleasecontact Slater & Gordon no later than Friday, 19 October 2012.

    You will be sent an Information Pack containing a Legal Costs Agreement and Litigation Funding Agreement which youwill need to execute and return with all relevant trading information.

    Persons who return executed documents by 19 October 2012 will be represented at mediation as Late FundedGroup Members, and all reasonable efforts will be made to include such persons in any settlement. Further, in the eventthat the proceeding does not settle at mediation, an application will be made to formally include Late Funded GroupMembers as Funded Group Members in the proceeding. If you return documents to us we will keep you informed as tothe outcome of the mediation and, if necessary, the outcome of any application to the Court.

    Contact

    Please respond without delay to: [email protected] or Call 1800 555 777

    If possible, please provide a spreadsheet or document containing the following information:1. The number of Sigma shares held as at 6 September 2009; and2. In relation to each trade in the relevant period (7 September 2009 to 25 February 2010):

    x Date of trade (contract/trade date not settlement date)

    x Whether Buy/Sell

    x Volume Bought/Sold

    x Price Paid/Received.

    Additional InformationFor more information go to:http://www.slatergordon.com.au/areas-of-practice/victoria/general-legal-services/class-actions/sigma